The FDA has launched an initiative to implement real-time clinical trials, with some outlets describing it as a proof-of-concept or pilot effort. The move is seen as an attempt to advance and transform the drug development process through the use of real-time data. Details of the initiative are still emerging, with the FDA seeking information and marking progress in its implementation.